Pitcairn’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,612
| Closed | -$522K | – | 617 |
|
|
2021
Q1 | $522K | Buy |
5,612
+1,135
| +25% | +$106K | 0.04% | 316 |
|
|
2020
Q4 | $401K | Sell |
4,477
-46
| -1% | -$4.12K | 0.03% | 354 |
|
|
2020
Q3 | $467K | Sell |
4,523
-567
| -11% | -$58.5K | 0.04% | 263 |
|
|
2020
Q2 | $402K | Buy |
5,090
+471
| +10% | +$37.2K | 0.04% | 271 |
|
|
2020
Q1 | $268K | Buy |
4,619
+309
| +7% | +$17.9K | 0.03% | 323 |
|
|
2019
Q4 | $233K | Sell |
4,310
-7,351
| -63% | -$397K | 0.02% | 481 |
|
|
2019
Q3 | $610K | Buy |
11,661
+419
| +4% | +$21.9K | 0.06% | 206 |
|
|
2019
Q2 | $543K | Sell |
11,242
-915
| -8% | -$44.2K | 0.05% | 228 |
|
|
2019
Q1 | $614K | Buy |
12,157
+5,106
| +72% | +$258K | 0.07% | 188 |
|
|
2018
Q4 | $418K | Buy |
7,051
+266
| +4% | +$15.8K | 0.05% | 221 |
|
|
2018
Q3 | $446K | Buy |
6,785
+873
| +15% | +$57.4K | 0.05% | 284 |
|
|
2018
Q2 | $298K | Buy |
5,912
+98
| +2% | +$4.94K | 0.03% | 398 |
|
|
2018
Q1 | $306K | Buy |
+5,814
| New | +$306K | 0.03% | 377 |
|
|
2016
Q2 | – | Sell |
-7,036
| Closed | -$255K | – | 462 |
|
|
2016
Q1 | $255K | Buy |
7,036
+893
| +15% | +$32.4K | 0.03% | 382 |
|
|
2015
Q4 | $246K | Buy |
+6,143
| New | +$246K | 0.03% | 382 |
|
|
2015
Q3 | – | Sell |
-7,078
| Closed | -$233K | – | 430 |
|
|
2015
Q2 | $233K | Sell |
7,078
-495
| -7% | -$16.3K | 0.03% | 415 |
|
|
2015
Q1 | $218K | Buy |
7,573
+219
| +3% | +$6.3K | 0.02% | 449 |
|
|
2014
Q4 | $200K | Buy |
+7,354
| New | +$200K | 0.02% | 465 |
|